Lipitoids, which self-assemble with DNA and RNA, can serve as cellular delivery systems for antiviral therapies that could prevent COVID-19 and other coronavirus infections. (Illustration courtesy of R.N. Zuckermann)

Scientists Aim Gene-Targeting Breakthrough Against COVID-19

Scientists at Berkeley Lab’s Molecular Foundry have joined forces with a research team at Stanford to aim a gene-targeting, antiviral agent called PAC-MAN against COVID-19.

Berkeley Lab News Center